Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, China.
Hubei Province Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
BMC Gastroenterol. 2022 Jul 29;22(1):363. doi: 10.1186/s12876-022-02447-y.
Targeted puncture of an appropriate portal venous branch during transjugular intrahepatic portosystemic shunt (TIPS) procedure may reduce the risk of postprocedural overt hepatic encephalopathy (HE). This study aimed to describe blood distribution under portography and combined it with puncture site to determine portal flow diversion, and to evaluate its prognostic value in predicting post-TIPS overt HE.
In this retrospective analysis of patients with cirrhosis undergoing TIPS, we included 252 patients to describe blood distribution under portography and 243 patients to assess the association between portal flow diversion and post-TIPS overt HE.
At the first stage, 51 (20.2%) patients were identified as type A (unilateral type with the right portal branch receives blood from splenic vein [SV]), 16 (6.4%) as type B (unilateral type with the right branch receives blood from superior mesenteric vein [SMV]) and 185 (73.4%) as type C (fully mixed type). At the second stage, 40 patients were divided into the SV group, 25 into the SMV group and 178 into the mixed group. Compared with the mixed group, the risk of post-TIPS overt HE was significantly higher in the SMV group (adjusted HR 3.70 [95% CI 2.01-6.80]; p < 0.001), whereas the SV group showed a non-significantly decreased risk (adjusted HR 0.57 [95% CI 0.22-1.48]; p = 0.25). Additionally, the SMV group showed a substantial increase in ammonia level at 3 days and 1 month after procedure.
Our results support the clinical use of portal flow diversion for risk stratification and decision-making in the management of post-TIPS overt HE.
经颈静脉肝内门体分流术(TIPS)过程中靶向穿刺合适的门静脉分支可能会降低术后显性肝性脑病(HE)的风险。本研究旨在描述门脉造影下的血液分布,并将其与穿刺部位相结合以确定门脉血流分流,并评估其预测 TIPS 术后显性 HE 的预后价值。
在这项回顾性分析中,我们纳入了 252 例接受 TIPS 治疗的肝硬化患者来描述门脉造影下的血液分布,纳入了 243 例患者来评估门脉血流分流与 TIPS 术后显性 HE 之间的关联。
在第一阶段,51 例(20.2%)患者被确定为 A 型(单侧型,右门静脉分支接受来自脾静脉[SV]的血液),16 例(6.4%)为 B 型(单侧型,右分支接受来自肠系膜上静脉[SMV]的血液),185 例(73.4%)为 C 型(完全混合型)。在第二阶段,40 例患者分为 SV 组,25 例患者分为 SMV 组,178 例患者分为混合组。与混合组相比,SMV 组 TIPS 术后显性 HE 的风险显著更高(调整后的 HR 3.70[95%CI 2.01-6.80];p<0.001),而 SV 组显示风险显著降低(调整后的 HR 0.57[95%CI 0.22-1.48];p=0.25)。此外,SMV 组在术后 3 天和 1 个月时的氨水平显著升高。
我们的结果支持在 TIPS 术后显性 HE 的管理中使用门脉血流分流进行风险分层和决策。